Correlation Between Aerovate Therapeutics and Baron Capital
Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and Baron Capital at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and Baron Capital into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aerovate Therapeutics and Baron Capital, you can compare the effects of market volatilities on Aerovate Therapeutics and Baron Capital and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of Baron Capital. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and Baron Capital.
Diversification Opportunities for Aerovate Therapeutics and Baron Capital
0.24 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Aerovate and Baron is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and Baron Capital in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Baron Capital and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with Baron Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Baron Capital has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and Baron Capital go up and down completely randomly.
Pair Corralation between Aerovate Therapeutics and Baron Capital
Given the investment horizon of 90 days Aerovate Therapeutics is expected to under-perform the Baron Capital. But the stock apears to be less risky and, when comparing its historical volatility, Aerovate Therapeutics is 13.26 times less risky than Baron Capital. The stock trades about -0.04 of its potential returns per unit of risk. The Baron Capital is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest 0.01 in Baron Capital on December 28, 2024 and sell it today you would earn a total of 0.01 from holding Baron Capital or generate 100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 96.77% |
Values | Daily Returns |
Aerovate Therapeutics vs. Baron Capital
Performance |
Timeline |
Aerovate Therapeutics |
Baron Capital |
Aerovate Therapeutics and Baron Capital Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Aerovate Therapeutics and Baron Capital
The main advantage of trading using opposite Aerovate Therapeutics and Baron Capital positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, Baron Capital can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Baron Capital will offset losses from the drop in Baron Capital's long position.Aerovate Therapeutics vs. Day One Biopharmaceuticals | Aerovate Therapeutics vs. Mirum Pharmaceuticals | Aerovate Therapeutics vs. Rocket Pharmaceuticals | Aerovate Therapeutics vs. Avidity Biosciences |
Baron Capital vs. Visa Class A | Baron Capital vs. Mastercard | Baron Capital vs. American Express | Baron Capital vs. PayPal Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |